Bromide

Bromide

SCHEMBL8001591

Br.Cc1cc(C)c(-c2csc(Br)n2)c(C)c1

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.39
SMN1; SMN2 Q16637 4/20 0.39
KDM4E B2RXH2 3/20 0.39
HTT P42858 2/20 0.39
POLB P06746 2/20 0.36
OPRM1 P35372 3/20 0.35
ALDH1A1 P00352 1/20 0.34
HSD17B10 Q99714 1/20 0.34
MAPT P10636 4/20 0.33
NPSR1 Q6W5P4 1/20 0.33
NPC1 O15118 2/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
ATM Q13315 1/20 0.32
MGAM O43451 1/20 0.32
GAA P10253 1/20 0.32
SI P14410 1/20 0.32
MGAM2 Q2M2H8 1/20 0.32
CRHR1 P34998 1/20 0.31
RAB9A P51151 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8013772 0.98 LMNA (0.39) LMNASMN1; SMN2KDM4EHTTPOLB
Bromide SCHEMBL7902851 0.81 ALDH1A1 (0.47) LMNASMN1; SMN2KDM4EHTTALDH1A1
SCHEMBL19626737 0.80 RECQL (0.44) LMNASMN1; SMN2KDM4EHTTPOLB
SCHEMBL2381398 0.78 ALDH1A1 (0.48) LMNASMN1; SMN2KDM4EHTTALDH1A1
SCHEMBL27346476 0.77 CYP19A1 (0.41) LMNASMN1; SMN2KDM4EHTTPOLB
SCHEMBL19625299 0.76 LMNA (0.38) LMNASMN1; SMN2KDM4EHTTPOLB
Hydrochloric Acid SCHEMBL8013241 0.76 CYP19A1 (0.40) LMNASMN1; SMN2KDM4EHTTPOLB
SCHEMBL2098453 0.73 LMNA (0.41) LMNASMN1; SMN2KDM4EHTTPOLB
SCHEMBL2092103 0.70 LMNA (0.40) LMNASMN1; SMN2KDM4EHTTPOLB
SCHEMBL2092106 0.70 MAPT (0.37) LMNASMN1; SMN2KDM4EHTTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6057318-A ANTAGONISTS OF PLATELET ACTIVATING FACTOR ACETHER SANOFI (FR) 2000-05-02 US disclosed
US-5891894-A 2-AMINO OXAZOLE DERIVATIVES; ANTAGONISTS OF PLATELET ACTIVATING FACTOR USEFUL IN TREATMENT OF ASTHMA, INFLAMMATION, CARDIOVASCULAR DISORDERS, RENAL DISEASES, OR AS CONTRACEPTIVES SANOFI (FR) 1999-04-06 US disclosed
US-5891893-A 5-AMINO-1,2,4-OXA(OR THIA)DIAZOLES; ANTAGONISTS OF PLATELET ACTIVATING FACTOR USEFUL IN TREATMENT OF ASTHMA, ALLERGIES, INFLAMMATION, CARDIOVASCULAR DISEASES, RENAL DISEASES, OR AS CONTRACEPTIVES SANOFI (FR) 1999-04-06 US disclosed
US-5780468-A ANTAGONIST OF PLATELET ACTIVATING FACTOR SANOFI (FR) 1998-07-14 US disclosed
US-5470855-A Anticoagulants SANOFI (FR) 1995-11-28 US disclosed
CN-1028757-C Heterocyclic derivatives, process for their preparation and their use as medicaments SANOFI SA (FR) 1995-06-07 CN disclosed
CN-1053064-A PROCESS FOR PREPARING HETEROCYCLIC DERIVATIVES SANOFI SA (FR) 1991-07-17 CN disclosed